Loading company…
Nostos Genomics develops AI-based tools to identify genetic diseases and interpret genetic variants.
Founded in 2018 and based in Berlin, Nostos Genomics develops machine learning tools for genetic disease identification. Its AION platform lets clinicians and researchers submit case data, including VCF files, family information, and patient characteristics, and generates reports on variants and associated diseases. In February 2022, the company raised EUR 5 million in seed funding from 42CAP, Acequia Capital, Entrepreneur First, and Amino Collective, at a stated EUR 11.86 post-money valuation.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in